Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-122
Closed -$1K 1213
2017
Q1
$1K Hold
122
﹤0.01% 1112
2016
Q4
$2K Sell
122
-119
-49% -$1.82K ﹤0.01% 1033
2016
Q3
$5K Sell
241
-125
-34% -$1.98K ﹤0.01% 982
2016
Q2
$6K Hold
366
﹤0.01% 977
2016
Q1
$6K Sell
366
-249
-40% -$4.44K ﹤0.01% 916
2015
Q4
$13K Hold
615
﹤0.01% 784
2015
Q3
$13K Buy
615
+355
+137% +$8.61K ﹤0.01% 816
2015
Q2
$6K Buy
+260
New +$6.38K ﹤0.01% 950

Other funds holding VXRT

MUFG Americas's VXRT Position: Q2 2017 in Review

MUFG Americas sold out of Vaxart (VXRT) in Q2 2017, closing a stake of 122 shares — an estimated $1K sold.

MUFG Americas first reported a position in VXRT in Q2 2015 and held it in 8 quarters. The position peaked at $13K in Q4 2015. 32 funds tracked by Wall St. Rank hold VXRT as of Q2 2017.

  • MUFG Americas reported no remaining Vaxart position as of Q2 2017 after selling out during the quarter.
  • MUFG Americas sold 122 Vaxart shares in Q2 2017, an estimated $1K.
  • MUFG Americas first reported a position in Vaxart in Q2 2015 and held it in 8 quarters.
  • MUFG Americas's Vaxart position peaked at $13K in Q4 2015.
  • 32 funds tracked by Wall St. Rank held Vaxart as of Q2 2017.

Based on MUFG Americas's 13F filing for Q2 2017, filed 7 Aug 2017.